Search
for
Sort by
Research 61–90 of 1000+
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Recent Therapy to Treat Various Types of Cancer: An Overview
- Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer
- Potential PRP Hair Treatment Side Effects
- Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Potential of nano-phytochemicals in cervical cancer therapy
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Chemical and green synthesis of nanoparticles and their efficacy on cancer cells
- The effectiveness of fermented wheat germ extract as an adjunct therapy in the treatment of cancer: A systematic review
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens
- BI39 Oncological therapies and hair disorders: a narrative approach on permanent chemotherapy-induced alopecia. A literature review of cancer-related therapies and their associated hair and scalp disorders
- Chemotherapy and Cutaneous Drug Reactions
- Periocular Manifestations of Afatinib Therapy
- A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
- Safety of testosterone treatment in postmenopausal women
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
- GYNECOMASTIA AFTER FINASTERIDE THERAPY
- Tumor Angiogenesis and Anti-angiogenic Therapy
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications